Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Nov;29(21):5639-44.
doi: 10.1128/MCB.00661-09. Epub 2009 Aug 31.

Regulating the activity of class II transactivator by posttranslational modifications: exploring the possibilities

Xiaoyan Wu  1 , Xiaocen Kong, Larry Luchsinger, Barbara D Smith, Yong Xu
Affiliations
Review

Regulating the activity of class II transactivator by posttranslational modifications: exploring the possibilities

Xiaoyan Wu et al. Mol Cell Biol. 2009 Nov.

Abstract

First identified as the master regulator of major histocompatibility complex II transcription, class II transactivator (CIITA) has since been implicated in a host of pathologies by modulating the transcription of multiple different genes. How CIITA caters to cell- and tissue-specific transcriptional needs is hotly debated and investigated. One of the possible mechanisms underlying spatiotemporal control of CIITA transcriptional activity is the posttranslational modification (PTM) machinery that refines certain amino acid residues of CIITA and hence alters its activity in response to specific cellular and environmental cues. This review discusses our current understanding of the PTM map of CIITA, how these modifications fine-tune its activity, and how the study of this area may lead to potential therapeutic strategies.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
A schematic map of known modification sites in CIITA. AD, activation domain; AT, acetyltransferase domain; PST, PST domain; GBD, GTP binding domain.
FIG. 2.
FIG. 2.
PTMs manipulate CIITA activity by different mechanisms. Specific covalent modifications can alter the subcellular localization of CIITA (A), interactions of CIITA with other factors and promoter selectivity (B and C), or stability of the CIITA protein (D).
See this image and copyright information in PMC

References

    1. Abbas, T., D. White, L. Hui, K. Yoshida, D. A. Foster, and J. Bargonetti. 2004. Inhibition of human p53 basal transcription by down-regulation of protein kinase Cdelta. J. Biol. Chem. 279:9970-9977. - PubMed
    1. Asher, G., D. Gatfield, M. Stratmann, H. Reinke, C. Dibner, F. Kreppel, R. Mostoslavsky, F. W. Alt, and U. Schibler. 2008. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 134:317-328. - PubMed
    1. Buttice, G., J. Miller, L. Wang, and B. D. Smith. 2006. Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells. Circ. Res. 98:472-479. - PMC - PubMed
    1. Cressman, D. E., K. C. Chin, D. J. Taxman, and J. P. Ting. 1999. A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome. Immunity 10:163-171. - PubMed
    1. Fikrig, E., S. W. Barthold, M. Chen, C. H. Chang, and R. A. Flavell. 1997. Protective antibodies develop, and murine Lyme arthritis regresses, in the absence of MHC class II and CD4+ T cells. J. Immunol. 159:5682-5686. - PubMed

Publication types

LinkOut - more resources